HEADER VIRAL PROTEIN 21-NOV-19 6V1W TITLE NMR STRUCTURE OF C-TERMINAL DOMAIN OF PHI29 ATPASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA PACKAGING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 223-332; COMPND 5 SYNONYM: ATPASE GP16,GENE PRODUCT 16,GP16,PROTEIN P16; COMPND 6 EC: 3.6.4.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS PHAGE PHI29; SOURCE 3 ORGANISM_TAXID: 10756; SOURCE 4 GENE: 16; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET30A KEYWDS VIRAL PACKAGING MOTOR, TERMINASE, RNASE H FOLD, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR B.MAHLER,H.MAO,M.C.MORAIS REVDAT 5 15-MAY-24 6V1W 1 REMARK REVDAT 4 14-JUN-23 6V1W 1 REMARK REVDAT 3 02-DEC-20 6V1W 1 JRNL REVDAT 2 04-NOV-20 6V1W 1 JRNL REVDAT 1 30-SEP-20 6V1W 0 JRNL AUTH B.P.MAHLER,P.J.BUJALOWSKI,H.MAO,E.A.DILL,P.J.JARDINE, JRNL AUTH 2 K.H.CHOI,M.C.MORAIS JRNL TITL NMR STRUCTURE OF A VESTIGIAL NUCLEASE PROVIDES INSIGHT INTO JRNL TITL 2 THE EVOLUTION OF FUNCTIONAL TRANSITIONS IN VIRAL DSDNA JRNL TITL 3 PACKAGING MOTORS. JRNL REF NUCLEIC ACIDS RES. V. 48 11737 2020 JRNL REFN ESSN 1362-4962 JRNL PMID 33089330 JRNL DOI 10.1093/NAR/GKAA874 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6V1W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1000245581. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1013 MBAR REMARK 210 SAMPLE CONTENTS : 1 UM [U-15N] PROTEIN, 50 MM MES, REMARK 210 90% H2O/10% D2O; 1 UM [U-13C] REMARK 210 PROTEIN, 50 MM [U-2H] MES, 99.9% REMARK 210 D2O; 1 UM U-15N, U-13C PROTEIN, REMARK 210 50 MM MES, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 15N NOESY-HSQC; 3D 13C-EDITED REMARK 210 NOESY-HSQC ALIPHATIC; 3D 13C- REMARK 210 EDITIED NOESY-HSQC AROMATIC; 3D REMARK 210 HSQC-NOESY-HSQC; HD-EXCHANGE; 3D REMARK 210 HNCA; 3D HNCACB; 3D CBCA(CO)NH; REMARK 210 3D HNCO; 3D 1H-15N TOCSY; 3D REMARK 210 HCCH-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.2, NMRPIPE, NMRVIEW REMARK 210 9.2.0, TALOS-N, X-PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST TOTAL ENERGY AND ZERO NOE REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 MET A 222 REMARK 465 LEU A 333 REMARK 465 GLU A 334 REMARK 465 HIS A 335 REMARK 465 HIS A 336 REMARK 465 HIS A 337 REMARK 465 HIS A 338 REMARK 465 HIS A 339 REMARK 465 HIS A 340 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 268 28.80 -140.17 REMARK 500 1 THR A 280 127.62 -30.50 REMARK 500 1 MET A 287 62.69 -114.26 REMARK 500 1 MET A 288 -128.74 -157.62 REMARK 500 2 ARG A 234 -72.05 -97.64 REMARK 500 2 THR A 266 75.20 -105.82 REMARK 500 2 PRO A 270 27.05 -79.35 REMARK 500 2 THR A 280 -169.88 -79.29 REMARK 500 2 GLU A 285 -72.49 -93.79 REMARK 500 2 LEU A 289 86.70 44.76 REMARK 500 3 ASP A 226 -6.07 -144.53 REMARK 500 3 ARG A 234 -71.94 -103.55 REMARK 500 3 ASN A 274 75.58 -113.83 REMARK 500 3 GLU A 285 -62.97 -99.31 REMARK 500 3 LEU A 289 75.91 65.61 REMARK 500 4 ARG A 234 -67.87 -102.54 REMARK 500 4 PRO A 270 30.99 -83.01 REMARK 500 4 GLU A 285 -65.61 -102.12 REMARK 500 4 MET A 288 -24.05 -148.41 REMARK 500 4 TYR A 293 0.37 -163.59 REMARK 500 5 THR A 266 78.25 -111.08 REMARK 500 5 THR A 280 -172.42 -67.59 REMARK 500 5 LEU A 289 95.23 50.78 REMARK 500 5 THR A 291 42.00 -82.56 REMARK 500 5 ILE A 331 91.55 47.74 REMARK 500 6 HIS A 268 -17.83 -143.87 REMARK 500 6 ASN A 274 73.21 -112.03 REMARK 500 6 GLU A 285 -68.46 -106.76 REMARK 500 6 ASN A 286 -8.73 -54.58 REMARK 500 6 MET A 288 -23.89 178.40 REMARK 500 7 ARG A 234 -66.50 -103.62 REMARK 500 7 SER A 238 121.91 -16.26 REMARK 500 7 HIS A 268 29.42 -142.01 REMARK 500 7 THR A 280 143.37 -38.54 REMARK 500 7 MET A 288 -12.17 -177.69 REMARK 500 7 ASN A 295 48.68 -82.35 REMARK 500 7 ILE A 331 154.64 53.15 REMARK 500 8 ARG A 234 -78.34 -110.76 REMARK 500 8 THR A 266 76.71 -109.10 REMARK 500 8 GLU A 285 -97.72 -107.06 REMARK 500 8 TYR A 293 9.09 -158.49 REMARK 500 8 ASN A 295 36.18 -97.76 REMARK 500 9 THR A 266 75.17 -106.41 REMARK 500 9 GLU A 285 -110.16 -103.21 REMARK 500 9 ASN A 286 24.44 47.17 REMARK 500 9 MET A 288 -100.33 71.27 REMARK 500 9 ASN A 292 38.88 -73.26 REMARK 500 9 ASN A 296 74.87 -102.19 REMARK 500 9 ILE A 331 12.19 52.77 REMARK 500 10 GLN A 228 85.55 56.12 REMARK 500 REMARK 500 THIS ENTRY HAS 96 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30691 RELATED DB: BMRB REMARK 900 NMR STRUCTURE OF C-TERMINAL DOMAIN OF PHI29 ATPASE DBREF 6V1W A 223 332 UNP P11014 PKG16_BPPH2 223 332 SEQADV 6V1W MET A 222 UNP P11014 INITIATING METHIONINE SEQADV 6V1W LEU A 333 UNP P11014 EXPRESSION TAG SEQADV 6V1W GLU A 334 UNP P11014 EXPRESSION TAG SEQADV 6V1W HIS A 335 UNP P11014 EXPRESSION TAG SEQADV 6V1W HIS A 336 UNP P11014 EXPRESSION TAG SEQADV 6V1W HIS A 337 UNP P11014 EXPRESSION TAG SEQADV 6V1W HIS A 338 UNP P11014 EXPRESSION TAG SEQADV 6V1W HIS A 339 UNP P11014 EXPRESSION TAG SEQADV 6V1W HIS A 340 UNP P11014 EXPRESSION TAG SEQRES 1 A 119 MET PHE ILE GLY ASP SER GLN VAL PHE ILE GLU LYS ARG SEQRES 2 A 119 SER LYS ASP SER LYS PHE VAL PHE SER ILE VAL TYR ASN SEQRES 3 A 119 GLY PHE THR LEU GLY VAL TRP VAL ASP VAL ASN GLN GLY SEQRES 4 A 119 LEU MET TYR ILE ASP THR ALA HIS ASP PRO SER THR LYS SEQRES 5 A 119 ASN VAL TYR THR LEU THR THR ASP ASP LEU ASN GLU ASN SEQRES 6 A 119 MET MET LEU ILE THR ASN TYR LYS ASN ASN TYR HIS LEU SEQRES 7 A 119 ARG LYS LEU ALA SER ALA PHE MET ASN GLY TYR LEU ARG SEQRES 8 A 119 PHE ASP ASN GLN VAL ILE ARG ASN ILE ALA TYR GLU LEU SEQRES 9 A 119 PHE ARG LYS MET ARG ILE GLN LEU GLU HIS HIS HIS HIS SEQRES 10 A 119 HIS HIS HELIX 1 AA1 ASN A 284 MET A 288 5 5 HELIX 2 AA2 TYR A 297 GLY A 309 1 13 HELIX 3 AA3 GLN A 316 ARG A 330 1 15 SHEET 1 AA1 4 LEU A 261 ASP A 265 0 SHEET 2 AA1 4 PHE A 249 ASP A 256 -1 N TRP A 254 O TYR A 263 SHEET 3 AA1 4 LYS A 239 TYR A 246 -1 N TYR A 246 O PHE A 249 SHEET 4 AA1 4 VAL A 275 LEU A 278 1 O LEU A 278 N VAL A 245 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1